Investors supportive despite pharma’s shrinking returns
A recent report on the cost of bringing an asset from discovery to the market place has increased significantly for pharmaceutical companies over the last four years but returns on their investments have not kept pace. This state-of-affairs has caused these firms to adjust their business plans accordingly.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter